Menu
/REGISTER
Montecito
Giving Guide
Loading...
You are here:  Home  >  'Amgen'
Latest

Speedy cancer care matters, now more than ever, Thousand Oaks’ Rabble Health finds in new study

By   /  Friday, July 23rd, 2021  /  Central Coast Health Watch, Latest news, Subscriber content  /  Comments Off on Speedy cancer care matters, now more than ever, Thousand Oaks’ Rabble Health finds in new study

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

FDA accuses Amgen of misleading advertising

By   /  Friday, July 16th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, Top Stories, Tri-County Economy, Tri-County Public Companies  /  No Comments

The U.S. Food and Drug Administration tagged Amgen with a letter July 7 that says the Thousand Oaks biotech firm made “misleading claims” in advertisements for its drug Neulasta, by suggesting it is more effective than biosimilar competitors. Neulasta is a prescription medication used to reduce infection risk from febrile neutropenia (a low level of Read More →

Read More →
Latest

FDA gives Amgen priority review for asthma treatment

By   /  Friday, July 9th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, Top Stories, Tri-County Economy, Tri-County Public Companies  /  No Comments

Thousand Oaks-based Amgen received a priority review for tezepelumab, a treatment for asthma, from the U.S. Food and Drug Administration, the biotech giant announced July 7. According to Amgen, tezepelumab is the first and only biologic to consistently and significantly reduce asthma exacerbations in a broad population of clients in phase 2 and 3 trials. Read More →

Read More →
Latest

Amgen’s new drug could be a blockbuster

By   /  Friday, June 4th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, right, Subscriber content, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen’s new drug could be a blockbuster

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

‘A big change’ on the way as some companies continue remote work

By   /  Friday, June 4th, 2021  /  Central Coast, East Ventura County, Latest news, middle, Real Estate, South Coast, Subscriber content, Technology, Top Stories, Tri-County Economy, West Ventura County  /  Comments Off on ‘A big change’ on the way as some companies continue remote work

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen reaches billion-dollar licensing deal with Japanese firm

By   /  Wednesday, June 2nd, 2021  /  Banking & Finance, Biotech, East Ventura County, Latest news, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen reaches billion-dollar licensing deal with Japanese firm

Amgen announced an agreement June 1 with Kyowa Kirin, a Japanese pharmaceutical company, to jointly develop and commercialize a human monoclonal antibody that Kyowa Kirin is developing to treat atopic dermatitis and other autoimmune diseases. The deal could be worth $1.25 billion or more. Amgen will led the development, manufacturing and commercialization for the treatment, Read More →

Read More →
Latest

Amgen gets FDA approval for potential billion-dollar drug

By   /  Friday, May 28th, 2021  /  Banking & Finance, Biotech, East Ventura County, Latest news, right, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen gets FDA approval for potential billion-dollar drug

Thousand Oaks-based Amgen won approval from the U.S. Food and Drug Administration on May 28 for its latest oral drug treatment, Lumakras, potentially adding another huge market for one of the largest biotech firms in the world. According to the Wall Street Journal, Amgen will charge $17,900 a month for the drug and analyst think Read More →

Read More →